By: Ambika Subramanian, Meherpreet Saluja

Digital therapeutics (DTx) are essentially evidence-based, clinically evaluated therapeutic interventions that are driven by software products to treat, manage, or prevent medical conditions. They are designed to give patients more control over their care by delivering necessary clinical outcomes.

Part 1 of this white paper seeks to explain what Digital Therapeutics are about, their approval and reimbursement process, the reasons for their rising popularity and limitations to mainstream acceptance.

Complete the form to access the white paper.

I give permission to collect the data above and use it to contact me.